Jefferies Initiates Buy Rating on Spectrum Brands
The firm set a $97 price target for the stock, citing significant potential upside compared to its current market valuation.
Updated on Oct. 15, 2026 in Stock Picks
Live Poll
Do you trust financial analyst ratings when making your own investment decisions?
Jefferies resumed coverage of Spectrum Brands Holdings on October 15, 2026, with a Buy rating and a $97 price target. Analysts project that shares have 26% upside potential as the company works to improve operations.
Why it matters
The firm expects productivity initiatives and recovering sales volumes to effectively offset persistent inflationary pressures. These operational improvements are projected to drive organic sales growth and adjusted EBITDA increases through 2028.
The $97 price target is based on an enterprise value-to-EBITDA multiple of 7.5 times, which includes a 5% discount applied to the valuation of peer companies. Analysts project adjusted EBITDA to reach $319 million in 2027 and $335 million by 2028.
The players
Jefferies
Jefferies is a global full-service investment banking and capital markets firm that provides advisory and research services to institutional clients.
Spectrum Brands Holdings
Spectrum Brands Holdings is a diversified consumer products company that manufactures and markets a range of home and personal care products.
The details
Jefferies notes that Spectrum Brands currently trades at a 30% discount relative to its two and three-year average valuation multiples. The investment bank anticipates organic sales growth will reach 2.4% in the 2028 financial year, up from 0.7% in 2027.
Timeline
October 15, 2026: Jefferies resumes coverage of Spectrum Brands.
Financial years 2022 and 2023: Spectrum Brands EBITDA recorded near trough levels.
Financial year 2027: Company expected to enter a transition period with projected $319 million EBITDA.
Financial year 2028: Projected $335 million EBITDA and 2.4% organic sales growth.
Market Dynamics
The current analyst outlook suggests a recovery path that departs from the period of compressed earnings observed during the 2022-2023 EBITDA trough levels. This projection mirrors a broader sector shift as companies attempt to navigate post-inflationary recovery cycles.
Retail investors should note that the current share price implies a lower 2028 EBITDA valuation of roughly $272 million compared to the $335 million projected by the firm. Investors might monitor how the firm's growth forecast for 2028 aligns with their own portfolio risk tolerance.
The takeaway
The firm views the current stock price as an entry point based on a valuation discount relative to historical norms. Investors are encouraged to focus on whether management successfully meets the projected EBITDA milestones in the coming fiscal years.
Further reading
For additional insights on market evaluations, visit the United States Stock Picks section.
Source note: This article includes information reported by Proactiveinvestors NA.
Live Poll
Do you trust financial analyst ratings when making your own investment decisions?
